SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted...

Cell-based gene therapy Breyanzi (lisocabtagene maraleucel) has been approved to treat adults with certain types of large B-cell lymphoma who have not responded to other systemic treatment, the U.S. Food...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CYTARABINE INJECTION Cytarabine Consumer Medicine Information What is in this leaflet This leaflet...